Related Experiment Video
Updated: Jun 9, 2026
14:56
Remote Laboratory Management: Respiratory Virus Diagnostics
Published on: April 6, 2019
Vaccine cold chain: Part 2. Training personnel and program management
Bonnie Rogers1, Kim Dennison, Nikki Adepoju
1North Carolina Occupational Safety and Health Education and Research Center and OHN Program, University of North Carolina, School of Public Health, Chapel Hill, NC 27599-7502, USA. rogersb@email.unc.edu
Summary
Proper vaccine storage and handling are crucial for ensuring vaccine efficacy and preventing insufficient immunity. This article emphasizes personnel training and robust program management for effective vaccine cold chain maintenance.
Area of Science:
- Public Health
- Immunization Practices
- Healthcare Management
Background:
- The Centers for Disease Control and Prevention (CDC) highlights issues with vaccine storage and handling in clinical settings.
- Inadequate practices can compromise vaccine integrity, leading to reduced vaccine effectiveness and insufficient immunity in vaccinated populations.
Purpose of the Study:
- To underscore the critical role of proper vaccine storage and handling.
- To provide guidance on essential personnel training and program management policies for maintaining an effective vaccine cold chain.
Main Methods:
- This article focuses on policy and procedural recommendations.
- It draws upon reports and guidelines from public health organizations like the CDC.
Main Results:
- Suboptimal vaccine storage and handling practices are identified as a significant concern.
- Effective vaccine cold chain management requires comprehensive training and established procedures.
Conclusions:
- Implementing and maintaining an effective vaccine cold chain is vital for public health.
- Adequate personnel training and strong program management policies are indispensable for ensuring vaccine efficacy and population immunity.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
01:51Vaccinations
Overview
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...